Synthesis and evaluation of geldanamycin-testosterone hybrids

Bioorganic and Medicinal Chemistry Letters

Volumn 10, Issue 11, 2000, Pages 1303-1306

  Kuduk, Scott D ^a   Harris, Christina R ^a   Zheng, Fuzhong F ^a   Sepp Lorenzino, Laura ^a   Ouerfelli, Quathek ^a   Rosen, Neal ^a   Danishefsky, Samuel J ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; CHAPERONE; GELDANAMYCIN; HYBRID PROTEIN;

ARTICLE; BREAST CANCER; CANCER CELL; CELL LINE; COLON CANCER; DRUG BINDING; DRUG CYTOTOXICITY; DRUG INHIBITION; DRUG POTENCY; DRUG SELECTIVITY; DRUG SYNTHESIS; PROSTATE CANCER; PROTEIN DEGRADATION;

ANTINEOPLASTIC AGENTS; BENZOQUINONES; DRUG EVALUATION; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; LACTAMS, MACROCYCLIC; NEOPLASMS, HORMONE-DEPENDENT; QUINONES; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN; TESTOSTERONE; TUMOR CELLS, CULTURED;

EID: 0034608532     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(00)00208-0     Document Type: Article

References (33)

1. (a) Uehara, Y.; Hori, M.; Takeuchi, T.; Umezawa, H. Jpn. J. Cancer. Res. 1985, 76, 672.
2. (b) Sasaki, K.; Rinehart, K. L.; Slomp, G.; Grostle, M. F.; Olson, E. C. J. Am. Chem. Soc. 1970, 92, 7591.
3. (a) Miller, P.; DiOrio, C.; Moyer, C.; Schnur, R. C.; Bruskin, A.; Cullen, W.; Moyer, J. D. Cancer Res. 1994, 54, 2724.
4. (b) Miller, P.; Schnur, R. C.; Babacci, E.; Moyer, M. P.; Moyer, J. D. Biochem. Biophys. Res. Comm. 1994, 210, 1313.
5. (a) Sepp-Lorenzino, L.; Ma, Z.; Lebwohl, D. E.; Vinitsky, A.; Rosen, N. J. Biol. Chem. 1995, 270, 16580.
6. (b) Whitesell, L.; Mimnaugh, E. G.; De Costa, B.; Myers, C. E.; Neckers, L. M. Proc. Natl. Acad. Sci. USA 1994, 91, 8324.
7. Stebbins C.E., Russo A.A., Schneider C., Rosen N., Hartl U., Pavletich N.P. Cell. 89:1997;239.
8. Prodromou C., Roe S.M., O'Brien R., Ladbury J.E., Piper P., Pearl L.H. Cell. 90:1997;65.
9. Prodromou C., Roe S.M., Piper P.W., Pearl L.H. Nat. Struct. Biol. 4:1997;477.
10. Roe S.M., Prodromou C., O'Brien R., Ladbury J.E., Piper P.W., Pearl L.H. J. Med. Chem. 42:1999;260.
11. For commentary on Hsp90 as a molecular chaperone and/or as a potential drug target see: (a) Scheibel, T.; Buchner, J. Biochem. Pharm. 1998, 56, 675
12. (b) Frydman, J.; Hohfeld, J. TIBS 1997, 22, 87.
13. (c) Hartl, F. U. Nature 1996, 381, 571.
14. (d) Csermely, P.; Schnaider, T.; Soti, C.; Prohaszka, Z.; Nardai, G. Pharmacol. Ther. 1998, 79, 129.
15. For a review of GDM and other naturally occurring molecules as targets for therapeutic intervention see: Cardenas, M. E.; Sanfridson, A.; Cutler, N. S.; Heitman, J. Trends Biotechnol. 1998, 16, 427.
16. For steroid receptors/immunophilins see: (a) Pratt, W. B.; Toft, D. O. Endocr. Rev. 1997, 306.
17. (b) Pratt, W. B. Proc. Soc. Exp. Biol. Med. 1998, 217, 420.
18. (c) Segnitz; B.; Gehring, U. J. Biol. Chem. 1997, 272, 18694.
19. (d) Fang, Y.; Fliss, A. E.; Robins, D. M.; Avrom, J. C. J. Biol. Chem. 1996, 271, 28697.
20. For Raf-1 see: (a) Stancato, L. F.; Silverstein, A. M.; Owens-Grillo, J. K.; Chow, Y. H.; Jove, R.; Pratt, W. B. J. Biol. Chem. 1997, 272, 4013.
21. (b) Wartmann, M.; Davis, R. J. J. Biol. Chem. 1994, 269, 6695.
22. Schneider C., Sepp-Lorenzino L., Nimmergsen E., Ouarfelli O., Danishefsky S., Rosen N. Proc. Natl. Acad. Sci. USA. 93:1996;14536.
23. For p53 see: (a) Whitesell, L.; Sutphin, P. D.; Pulcini, E. J.; Martinez, J. D.; Cook, P. H. Mol. Cell Biol. 1998, 18, 1517.
24. (b) Dasgupta, G.; Momand, J. Exp. Cell Res. 1997, 237, 29.
25. Research done at MSKCC.
26. Kuduk S.D., Zheng F.F., Sepp-Lorenzino L., Rosen N., Danishefsky S. J. Bioorg. Med. Chem. Lett. 9:1999;1233.
27. (a) Horwell, D. C.; Lennon, I. C.; Roberts, E. Tetrahedron 1994, 50, 4225.
28. (b) Kataoka, H.; Watanabe, K.; Miyazaki, K.-i.; Tahara, S.-i.; Ogu, K.-i.; Matsuoka, R.; Goto, K. Chem. Lett. 1990, 1705.
29. Liu A., Carlson K.E., Katzenellenbogen J.A. J. Med. Chem. 35:1992;2113.
30. (a) Schnur, R. C.; Corman, M. L.; Gallaschun, R. J.; Cooper, B. A.; Dee, M. F.; Doty, J. L.; Muzzi, M. L.; Moyer, J. D.; DiOrio, C. I.; Barbacci, E. G. J. Med. Chem. 1995, 38, 3806.
31. (b) Schnur, R. C.; Corman, M. L.; Gallaschun R. J.; Cooper, B. A.; Dee, M. F.; Doty, J. L.; Muzzi, M. L.; DiOrio, C. I.; Barbacci, E. G.; Miller P. E. J. Med. Chem. 1995, 38, 3813.
32. 13C) and exact mass (HRMS).
33. Zheng, F. F. unreported results.